Loading Events

« All Events

  • This event has passed.


May 21


‘The potential role of precision medicine in altering the poor outcomes the pancreas cancer’

Tuesday 21 May, 12.30pm – 1.30pm | Online Webinar

The NSW Regional Cancer Research Network, in collaboration with the Maridulu Budyari Gumal (SPHERE) Cancer CAG and Sydney Cancer Partners host the 2024 NSW Cancer Research Education State-wide Seminar Series. These online seminars are held on the 3rd Tuesday of each month.

Session Information

Pancreatic cancer has a poor prognosis and an urgent need for new effective treatments. In this educational Molecular Tumour Board session, we will hear an update on the molecular features of pancreatic cancer and their relevance to clinical management. This will be followed by a series of informative case presentations with discussion from an expert multi-disciplinary team. The session will give insight to the clinical interpretation of molecular data, its relevance in current practice and the opportunities it presents for improving pancreatic cancer outcomes.


Dr Frank Lin is a medical oncologist and clinical informatician based in Sydney. He currently holds conjoint research appointments at the Garvan Institute of Medical Research, NHMRC Clinical Trials Centre (University of Sydney), and the Maridulu Budyari Gumal (SPHERE) Cancer Clinical Academic Group (UNSW, Sydney).

Dr Milita Zaheed is a Medical Oncologist and works as a staff specialist in Cancer Genetics at The Prince of Wales Hospital. She is the medical lead for ACT Cancer Genetics service.

Dr John Grady is a Senior Bioinformatics Software Engineer at the Garvan Institute and is responsible for the bioinformatics of the MoST (Molecular Screening and Therapeutics) Program at the Garvan Institute.

Professor David Goldstein is a senior medical oncologist oncology, with multifaceted clinical interests, centring on the treatment of gastrointestinal malignancies including pancreas cancer, colorectal cancers, anal carcinoma, hepatobiliary, upper gastrointestinal malignancy.

Session Chair

Clinical Professor Rosemary Balleine is a Research Pathologist working in the field of translational cancer research. She has long-standing connections to health services and translational research initiatives in western Sydney.


Please select ‘NSW Regional Cancer Research Network’ as the Centre to which you belong.


May 21
Event Category: